Guardant Health (NasdaqGS:GH) has launched the Shield Across America mobile screening tour to promote its FDA approved blood test for colorectal cancer. The tour is scheduled to reach more than 100 ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of Shield Across America, a historic coast-to-coast mobile screening tour bringing Shield, the ...
Heaven’s Beverley Mitchell reflected on a life-changing experience when doctors found the “biggest precancerous polyp” on her ...
Patrick Dempsey, actor and cancer advocate, shares his experience getting screened for colorectal cancer with Shield by ...
Stockhead on MSN
Rhythm wins NATA accreditation for ColoSTAT colorectal cancer blood test, paving way for Australian launch
Rhythm’s ColoSTAT blood test for colorectal cancer accredited by The National Association of Testing Authorities ... Read More The post Rhythm wins NATA accreditation for ColoSTAT colorectal cancer ...
Wanderlust Travel Videos on MSN
Walking through historic Cebu City Colon Street
This walking tour explores Old Cebu City in the Philippines, including the historic Colon Street area. The video shows everyday street life, historic buildings, local shops, and the atmosphere of one ...
Sarah Beran, a mom of two and founder of Worldclass Clothing, shares how she managed to balance motherhood with her brave ...
With hundreds of new cases expected this year, early detection of colorectal cancer can mean a 91% survival rate.
Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported ...
AcuityMD, the intelligence platform for MedTech, announced data revealing increased access to colorectal screening and early treatment at ambulatory surgery centers (ASCs). Across ...
Experts have begun the first immunotherapy clinical trial in Nigeria to treat colorectal cancer, saying the treatment offers new hope to patients battling an advanced stage of the disease.They said ...
9don MSN
Monday's Daily Dose: GLP-1 eye risks, colorectal cancer in the young, and the glyphosate debate
A father blindsided by a cancer diagnosis, popular weight-loss drug with unexpected side effect, and a chemical causing controversy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results